The ABCs of The FDA: America’s Public Health Regulatory Agency

Unbiased Science

@unbiasedscipod

Education, Science, Health & Fitness

4.4 • 644 Ratings

🗓️ 13 November 2024

⏱️ 38 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

In this episode, Dr. Jessica Steier and Dr. Sarah Scheinman welcome Dr. Namandjé Bumpus, Principal Deputy Commissioner of the FDA, who shares insights into the agency's operations and her path from academia to FDA leadership. The scientists explore the complexities of drug approval processes, the FDA's organizational structure, and its commitment to safety and transparency. Dr. Bumpus discusses the agency's efforts to advance health equity and adapt to emerging technologies, while addressing the critical challenge of maintaining public trust. This conversation offers listeners a unique glimpse into the inner workings of the FDA and its role in protecting public health. All our sources from this episode are available at: https://www.unbiasedscipod.com/episodes/ (00:00) Introduction (03:31) Dr. Bumpus' Academic and Professional Journey (06:19) Transition from Academia to FDA Leadership (09:10) The Role of Pharmacology in Public Health (12:26) Overview of FDA Offices and Centers (15:10) Understanding the Drug Approval Process (18:12) Post-Market Surveillance and Drug Safety (21:20) Building Trust in Government Agencies (24:27) Examples of FDA's Impact on Public Health (27:16) Ensuring Transparency in FDA Processes (30:27) The Human Foods Program and Its Importance (33:08) Adapting to Rapidly Evolving Technologies (36:16) Challenges Facing the FDA and Public Health (38:42) Final Thoughts Interested in advertising with us? Please reach out to advertising@airwavemedia.com, with “Unbiased Science” in the subject line. PLEASE NOTE: The discussion and information provided in this podcast are for general educational, scientific, and informational purposes only and are not intended as, and should not be treated as, medical or other professional advice for any particular individual or individuals. Every person and medical issue is different, and diagnosis and treatment requires consideration of specific facts often unique to the individual. As such, the information contained in this podcast should not be used as a substitute for consultation with and/or treatment by a doctor or other medical professional. If you are experiencing any medical issue or have any medical concern, you should consult with a doctor or other medical professional. Further, due to the inherent limitations of a podcast such as this as well as ongoing scientific developments, we do not guarantee the completeness or accuracy of the information or analysis provided in this podcast, although, of course we always endeavor to provide comprehensive information and analysis. In no event may Unbiased Science or any of the participants in this podcast be held liable to the listener or anyone else for any decision allegedly made or action allegedly taken or not taken allegedly in reliance on the discussion or information in this podcast or for any damages allegedly resulting from such reliance. The information provided herein do not represent the views of our employers.

Transcript

Click on a timestamp to play from that location

0:00.0	You're listening to an Airwave Media podcast.
0:26.5	Welcome to Unbiased Science, where we bring scientific method to the madness.
0:30.7	We're hosts Dr. Jess Steyer and Dr. Sarah Scheinman.
0:36.6	And I'm not going to lie, today my public health heart is a flutter right now. We are going to have a conversation with the FDA,
0:41.8	the U.S. Public Health Regulatory Agency. We are extremely honored and excited to welcome Dr.
0:48.9	Namange Bumpus. Thank you so much for joining us today. Thank you for having me.
0:52.9	So before we dig in, we have
0:54.5	lots of questions. I'd like to read a little bit of a bio. Dr. Namange Bumpus became the FDA's
1:02.7	principal deputy commissioner on February 1st, 2024. In this role, she works closely with FDA
1:09.5	leadership to develop, advance, and implement key
1:12.8	public health initiatives, as well as to oversee the agency's day-to-day functions. Chief
1:18.9	among those priorities is the reorganization unifying the Human Foods program, creating a new
1:24.6	model for the Office of Regulatory Affairs, and strengthening the entire
1:28.8	agency. Dr. Bumpus has played an integral leadership role in the implementation and change
1:34.9	management group and will provide seamless transition for this critical modernization effort.
1:40.8	Again, Dr. Bumpus, thanks so much again for joining us. If I could just jump in with a
1:46.9	question, because I think inquiring minds want to know, so can you walk us through your
1:53.6	academic and professional journey that led to your current role? Yes, sure. And before I
1:59.7	became the FDA principal deputy commissioner, I came here
2:02.0	originally as the chief scientist in August 2022. So my background academically starts with a bachelor's
2:13.0	degree in biology at Occidental College in Los Angeles. I wanted to be a scientist my whole life from the time
2:20.0	I was about five years old and so was really excited to get to pursue that. After Occidental, I went
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from @unbiasedscipod, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of @unbiasedscipod and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.